Clinical Trials Directory

Trials / Conditions / Stage IV Pancreatic Cancer AJCC v6 and v7

Stage IV Pancreatic Cancer AJCC v6 and v7

20 registered clinical trials studyying Stage IV Pancreatic Cancer AJCC v6 and v7 — 1 currently recruiting.

StatusTrialSponsorPhase
RecruitingCollecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
NCT05334069
Alliance for Clinical Trials in Oncology—
TerminatedCD8+ T Cell Therapy and Pembrolizumab in Treating Patients With Metastatic Gastrointestinal Tumors
NCT02757391
M.D. Anderson Cancer CenterPhase 1
Active Not RecruitingLiposomal Irinotecan, Fluorouracil, Leucovorin Calcium, and Rucaparib in Treating Patients With Metastatic Pan
NCT03337087
Academic and Community Cancer Research UnitedPhase 1 / Phase 2
Active Not RecruitingGuadecitabine and Durvalumab in Treating Patients With Advanced Liver, Pancreatic, Bile Duct, or Gallbladder C
NCT03257761
University of Southern CaliforniaPhase 1
CompletedSelumetinib Sulfate in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer With KRAS G12R
NCT03040986
National Cancer Institute (NCI)Phase 2
CompletedPembrolizumab and CXCR4 Antagonist BL-8040 in Treating Patients With Metastatic Pancreatic Cancer
NCT02907099
M.D. Anderson Cancer CenterPhase 2
CompletedOlaparib in Treating Patients With Stage IV Pancreatic Cancer
NCT02677038
M.D. Anderson Cancer CenterPhase 2
Active Not RecruitingHypofractionated Stereotactic Body Radiation & Fluorouracil or Capecitabine for Locally Advanced Pancreatic Ca
NCT03073785
University of NebraskaPhase 2
Active Not RecruitingFOLFIRI or Modified FOLFIRI and Veliparib as Second Line Therapy in Treating Patients With Metastatic Pancreat
NCT02890355
National Cancer Institute (NCI)Phase 2
Active Not RecruitingA Phase 2 Study of Cediranib in Combination With Olaparib in Advanced Solid Tumors
NCT02498613
National Cancer Institute (NCI)Phase 2
Active Not RecruitingPersonalized Peptide Vaccine in Treating Patients With Advanced Pancreatic Cancer or Colorectal Cancer
NCT02600949
M.D. Anderson Cancer CenterPhase 1
Active Not RecruitingRopidoxuridine in Treating Patients With Advanced Gastrointestinal Cancer Undergoing Radiation Therapy
NCT02381561
National Cancer Institute (NCI)Phase 1
Active Not RecruitingGemcitabine Hydrochloride, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Metformin Hydrochloride, an
NCT02336087
City of Hope Medical CenterPhase 1
CompletedPaclitaxel Albumin-Stabilized Nanoparticle Formulation and Gemcitabine Hydrochloride With or Without WEE1 Inhi
NCT02194829
National Cancer Institute (NCI)Phase 1 / Phase 2
CompletedDinaciclib and Akt Inhibitor MK2206 in Treating Patients With Pancreatic Cancer That Cannot Be Removed by Surg
NCT01783171
National Cancer Institute (NCI)Phase 1
CompletedRomidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfun
NCT01638533
National Cancer Institute (NCI)Phase 1
Active Not RecruitingGemcitabine Hydrochloride, Dasatinib, and Erlotinib Hydrochloride in Treating Patients With Pancreatic Cancer
NCT01660971
National Cancer Institute (NCI)Phase 1
Active Not RecruitingVaccine Therapy and Sargramostim in Treating Patients With Pancreas Cancer That Cannot Be Removed By Surgery
NCT00669734
National Cancer Institute (NCI)Phase 1
CompletedGemcitabine Hydrochloride With or Without Vismodegib in Treating Patients With Recurrent or Metastatic Pancrea
NCT01064622
National Cancer Institute (NCI)Phase 2
Active Not RecruitingGDC-0449 and Erlotinib Hydrochloride With or Without Gemcitabine Hydrochloride in Treating Patients With Metas
NCT00878163
National Cancer Institute (NCI)Phase 1